Talaris Therapeutics, Inc. Profile Avatar - Palmy Investing

Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ tran…

Biotechnology
US, Louisville [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Talaris Therapeutics, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of TALS's Analysis
CIK: - CUSIP: 87410C104 LEI: - UEI: -
Secondary Listings
TALS has no secondary listings inside our databases.